Skip to content
Pfizer's Dividend Dream: Wait for Growth episode artwork

May 3, 2026 1 min

Pfizer's Dividend Dream: Wait for Growth

from The Daily News Now! Business

Pfizers stock, currently undervalued due to falling COVID vaccine sales and patent cliffs, presents a lucrative opportunity for dividend-focused investors. Despite challenges, Pfizer is actively expanding its portfolio with promising drugs and strategic partnerships. Offering a high dividend yield, its a solid income play with potential for significant growth if their innovations succeed. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/b69a21e75f2b2364

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Pfizer's Dividend Dream: Wait for Growth

0:00 1:21

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 3, 2026.

Can I download this The Daily News Now! Business episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.